- STENT ANGIOPLASTY IN TREATMENT OF CORONARY HEART DISEASE
M. Merić, I. Terzić, Z. Kušljugić and E. Halilović.
Clinic, University Clinical Center Tuzla, Bosnia and Herzegovina
stenting has become the primary therapeutic option for percutaneous
treatment of many coronary lesions, since the risk of subacute
stent thrombosis and bleeding complications has been reduced due
to the new antithrombotic regimens, new stent construction, coated
stents and high pressure stent expansion. Since September 1998,
243 patients i.e. 274 coronary lesions were subject of stent implantation
in our institution. 215 patients had single vessel disease, 25
patients had stents on two vessels and 3 patients had three vessel
diseases. Primary stenting was performed in 92 patients. Out of
total number of patients, there were 194 males and 49 females.
Most of the lesions were on LAD (198 patients), in 36 patients
lesions were on CX and in 40 patients on RCA. Stenosis diameter
before the procedure was 82% and after the procedure average diameter
was 5%. There were no peri-procedural deaths, non-fatal Q or non
Q wave infarctions or stroke. 5 patients had abrupt closure out
of which one was treated surgically, 4 were solved with PTCA or
stent. Subacute occlusion was observed in 3 patients (mean time
7 days), while two patients died. Repeated revascularisation was
performed with PTCA in 3 patients and 1 patient was referred to
surgery after 3 to 7 months. None of patients had bleeding complications
associated with transfusion or vascular surgery.